Schoenbaum, Geoffrey
- National Institute On Drug Abuse (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #3,042
- Sustained Excellence
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2012 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$2.3M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#3,042
By linked amount among FY2023 PIs
Earliest Year Loaded
2012
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Schoenbaum, Geoffrey as a PI. Multi-PI records show the full award amount for context.
- 1ZIADA000587-12ZIAContact PIAssociative learning, decision-making, and addiction$1.9Maward amount
- 1ZIADA000645-01ZIAContact PICHARACTERIZATION OF COGNITIVE INFERENCE IN A RODENT MODEL OF HIV-ASSOCIATED NEUROCOGNITIVE DISORDER$400Kaward amount
Award organization
Organizations that administered FY2023 awards listing Schoenbaum, Geoffrey as a PI.
FY2023 award administered by National Institute On Drug Abuse ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2012First NIH AwardNational Institute On Drug Abuse
- 2012$500K Cumulative Funding
- 2012$1M Cumulative Funding
- 2012$2M Cumulative Funding
- 2012Entered Top 50% NationallyRanked #1617
- 2012Entered Top 25% NationallyRanked #1617
- 2012Entered Top 10% NationallyRanked #1617
- 2013$5M Cumulative Funding
- 2015$10M Cumulative Funding
- 2019$25M Cumulative Funding
- 2022Entered Top 5% NationallyRanked #987